More Post from the Author
- Climate Activists Exploit Jasper Wildfire Anniversary - ICJ did no Due Diligence says Friends of Science Society
- Broadridge Schedules Webcast and Conference Call to Review Fourth Quarter and Fiscal Year 2025 Results on August 5, 2025
- AveriSource announces availability of AI-Powered Modernization Platform in the new AWS Marketplace AI Agents and Tools category
- OysterLink Reports Surge in Controversial Restaurant Fee Talks
- PRIVACY ALERT: House of Dior Under Investigation for Data Breach of Customer Records
Immunovia publishes the Annual Report for 2024
LUND, Sweden, April 2, 2025 /PRNewswire/ -- Immunovia AB (publ) today announced that the Annual Report for 2024 has been published.
The annual report can be downloaded in pdf format and is available on Immunovia's website.
For more information, please contact:
Jeff Borcherding
CEO and President
[emailprotected]
Immunovia in brief
Immunovia AB (IMMNOV: Nasdaq Stockholm), is a diagnostic company whose mission is to increase survival rates for patients with pancreatic cancer through early detection. Immunovia is focused on the development and commercialization of simple blood-based testing to detect proteins and antibodies that indicate a high-risk individual has developed pancreatic cancer.
Immunovia collaborates and engages with healthcare providers, leading experts and patient advocacy groups to make its test available to individuals at increased risk for pancreatic cancer.
USA is the world's largest market for detection of pancreatic cancer. The company estimates that in the USA, 1.8 million individuals are at high-risk for pancreatic cancer and could benefit from annual surveillance testing.
Immunovia's shares (IMMNOV) are listed on Nasdaq Stockholm. For more information, please visitwww.immunovia.com
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/immunovia-ab/r/immunovia-publishes-the-annual-report-for-2024,c4129259
The following files are available for download:
Annual Report 2024 |
SOURCE Immunovia AB

More Post from the Author
- Climate Activists Exploit Jasper Wildfire Anniversary - ICJ did no Due Diligence says Friends of Science Society
- Broadridge Schedules Webcast and Conference Call to Review Fourth Quarter and Fiscal Year 2025 Results on August 5, 2025
- AveriSource announces availability of AI-Powered Modernization Platform in the new AWS Marketplace AI Agents and Tools category
- OysterLink Reports Surge in Controversial Restaurant Fee Talks
- PRIVACY ALERT: House of Dior Under Investigation for Data Breach of Customer Records